Federal Agency · Defense Health Agency Contracting Activity - DHACA
DoW Parkinson’s, Investigator-Initiated Research Award
Last updated: September 6, 2026
Posted June 18, 2026
Funding
Funding amount not specified
Closes
November 6, 2026
NAICS
541715
Summary: The fiscal year 2026 (FY26) Parkinson’s Research Program (PRP) Investigator-Initiated Research Award (IIRA) supports highly rigorous, multidisciplinary, high-impact research projects that have the potential to make an important contribution to Parkinson’s disease research. Research must address at least one of the four FY26 PRP Focus Areas . Distinctive Features: · Partnering Principal Investigator (PI) Option: Allows for more than one PI. One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. The other PI(s) will be identified as Partnering PI(s), with a maximum of two Partnering PIs. · Preliminary data are required. · Clinical trials are allowed. Program Details Defense Health Agency Contracting Activity - DHACA is a federal agency that offers the DoW Parkinson’s, Investigator-Initiated Research Award grant program to support eligible programs and projects. This funding opportunity is available nationally and is administered by Defense Health Agency Contracting Activity - DHACA through Grants.gov. Organizations seeking funding for eligible programs and projects should review the details below and confirm their eligibility before preparing an application. Eligibility Eligible applicants include eligible organizations. Organizations that meet the eligibility criteria are encouraged to apply and to review the full program guidelines before submission. Because eligibility rules and funding priorities can change between cycles, applicants should always confirm the current requirements with Defense Health Agency Contracting Activity - DHACA or on Grants.gov before investing time in an application. Funding and Timeline The application deadline is November 6, 2026 (60 days remaining). Applicants should allow sufficient time to gather required documentation, including organizational information, project descriptions, budgets, and supporting materials as specified in the program guidelines. Submitting a complete application well ahead of the deadline reduces the risk of disqualification on technical or administrative grounds. Program Focus This grant supports eligible programs and projects. This grant is associated with NAICS industry classifications: 541715, 336. Organizations operating in these sectors are encouraged to review eligibility. Funded projects are expected to demonstrate measurable outcomes aligned with the program's stated objectives. Grant recipients may be required to submit progress reports and final evaluations as a condition of the award, and to retain records for audit and compliance purposes. How to Apply Eligible organizations can apply through Grants.gov. Create a free organization profile on GrantRegister to see whether this grant matches your organization's NAICS code, entity type, location, and focus area, and to receive a weekly digest of every open grant you qualify for. GrantRegister maintains a complete, authoritative registry of US federal, state, and foundation grant opportunities — matched automatically to your organization profile and delivered every Monday.
Eligibility
- Funded by DoD-generic
Award details
Applications close on November 6, 2026 (60 days remaining).
Categories
Not categorized
Sign up at GrantRegister to see if this grant matches your organization.
Match my organization →View application on Grants.gov →·Source: Grants.gov·Last seen Sep 6, 2026
Similar grants
- Applied Drug Policy Research ExperiencesOffice of National Drug Control Policy · closes September 6, 2026
- Building Lasting U.S.-Chad Partnerships to Promote American ExcellenceU.S. Mission to Chad · closes September 6, 2026
- Alcohol Health Services Research (R01 Clinical Trial Optional)National Institutes of Health · closes September 7, 2026
- Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)National Institutes of Health · closes September 7, 2026
- Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)National Institutes of Health · closes September 7, 2026
- Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)National Institutes of Health · closes September 7, 2026
- Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)National Institutes of Health · closes September 7, 2026
- National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)National Institutes of Health · closes September 7, 2026
